Spots Global Cancer Trial Database for R2 in the Treatment of Follicular Lymphoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: R2 in the Treatment of Follicular Lymphoma
Official Title: R2 in the Treatment of Follicular Lymphoma Grade 1-3A
Study ID: NCT03715309
Conditions
Follicular Lymphoma
Interventions
Revlimid
Study Description
Brief Summary: Lenalidomide Based Immunotherapy in the Treatment of FL
Detailed Description: Lenalidomide Based Immunotherapy efficacy related molecular biomarker in follicular lymphoma
Keywords
Eligibility
Minimum Age: 16 Years
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Ruijin Hospital, Shanghai, Shanghai, China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
